PYXS
Pyxis Oncology·NASDAQ
--
--(--)
--
--(--)
1.95 / 10
Underperform
Technical analysis rates PYXS Underperform with a 1.95/10 score. Recent signals show Long Upper Shadow, MACD Death Cross and Long Lower Shadow, all bearish. No bullish indicators appear, indicating a fragile price structure and downside risk.
Analysis Checks(0/3)
Long Upper Shadow
Score2.36/10
Win Rate46.48%
Hist. Signals71
Avg Return-0.23%
Score2.36/10
Win Rate46.48%
Hist. Signals71
Avg Return-0.23%
MACD Death Cross
Score1/10
Win Rate28.57%
Hist. Signals7
Avg Return-1.62%
Score1/10
Win Rate28.57%
Hist. Signals7
Avg Return-1.62%
Long Lower Shadow
Score2.48/10
Win Rate45.31%
Hist. Signals64
Avg Return0.38%
Score2.48/10
Win Rate45.31%
Hist. Signals64
Avg Return0.38%
Long Upper Shadow
Score2.36/10
Win Rate46.48%
Hist. Signals71
Avg Return-0.23%
Score2.36/10
Win Rate46.48%
Hist. Signals71
Avg Return-0.23%
Long Lower Shadow
Score2.48/10
Win Rate45.31%
Hist. Signals64
Avg Return0.38%
Score2.48/10
Win Rate45.31%
Hist. Signals64
Avg Return0.38%
MACD Death Cross
Score1/10
Win Rate28.57%
Hist. Signals7
Avg Return-1.62%
Score1/10
Win Rate28.57%
Hist. Signals7
Avg Return-1.62%
Technical Analysis of PYXS?
- PYXS presents a Underperform setup with a Technical Score of 1.95/10. Key technical indicators highlight an RSI of 50.70 and a MACD of 0.01, with the trend anchored by the 50-Day SMA at 1.47. Traders should monitor key support at 1.43 and resistance at 1.53.
